Current stock page

Catalysts

HUM Stock Catalysts

Earnings · Growth Drivers · Events · AIQ Catalyst

HealthcareMedical - Healthcare PlansScore data as of Nov 13, 2026

HUMHumana Inc.

Healthcare / Medical - Healthcare Plans

Leader

Strong Relative Position

BullishEdge 9/10
$450.00+$6.32 (+1.42%)

Latest quote

  • Momentum
    89
  • Value
    76
  • Quality
    50
  • Risk resilience
    67
  • Sentiment
    —
algovestiq.comScore data as of Nov 13, 2026

Stock Catalyst Board

Earnings timing, analyst expectations, news pressure, growth drivers, events, and AIQ Catalyst context.

Next earnings
Feb 10, 2027

Upcoming reporting date available for this company.

AIQ Catalyst
AIQ 71/100

Momentum 89/100 and sentiment — before the next covered event.

Recent coverage
5 articles

Updated Nov 15, 2026 · Sentiment 44.79%

Earnings History And Surprises

See whether reported EPS and revenue have consistently exceeded or missed analyst expectations.

Earnings Expectations And Results

Compare what analysts expected with what the company reported across recent quarters.

Momentum 89/100AIQ Edge 9/10 Strong Relative Position
Beat rate
100%
8 of 8 reported periods
Average surprise
+8.9%
Across covered historical reports
Latest result
+30.0%
Nov 6, 2026
EPS estimate versus actual
Actual bars are colored by beat, inline result, or miss.
Earnings history
Report dateFiscal periodEPS estimateEPS actualEPS surpriseRevenue estimateRevenue actual
Nov 6, 2026—-$1.00-$0.70+30.0%$40.87B$41.16B
Jul 29, 2026—$7.27$7.61+4.7%$40.58B$40.87B
Apr 29, 2026—$10.24$10.31+0.7%$39.37B$39.65B
Feb 11, 2026—-$4.00-$3.96+1.0%$32.04B$32.52B
Nov 5, 2025—$2.93$3.24+10.6%$32B$32.65B
Jul 30, 2025—$5.92$6.27+5.9%$31.87B$32.39B
Apr 30, 2025—$10.07$11.58+15.0%$32.2B$32.11B
Feb 11, 2025—-$2.23-$2.16+3.1%$28.81B$29.21B

Analyst Forecast And Price Targets

Wall Street consensus, rating distribution, and the current 12-month target range.

Analyst ratings
Buy
16
Buy
9
Hold
1
Sell
12-month analyst target
$508.40
+12.98% versus current price
Based on 26 analyst observations. Targets are estimates, not predictions.
Low target
$420.00
-6.67% vs latest price
Average target
$508.40
+12.98% vs latest price
High target
$596.00
+32.44% vs latest price

Event Read

Catalysts should explain what can change the setup, when it might happen, and which AIQ component would move first.

Current event setup

Event dateFeb 10, 2027

Next known earnings or reporting date.

EPS estimate-$7.60

Current analyst expectation for the upcoming report.

Revenue estimate$41.35B

Current analyst expectation for the upcoming report.

Sentiment score—

News pressure around the setup.

Momentum score89

Where event reaction would show up first.

AIQ score71/100

Composite decision read before event confirmation.

Analyst context

Consensus
Buy
Analysts
26
Average target
$508.40
Target upside
12.98%
Target range
$420.00 - $596.00
90-day revisions
-23

News And Sentiment

Recent company coverage, scored where source sentiment is available.

Positive
4
Neutral
1
Negative
0
seekingalpha.com · Nov 6, 2026

Humana Inc. (HUM) Q3 2026 Earnings Call Transcript

Humana Inc. (HUM) Q3 2026 Earnings Call November 6, 2026 8:00 AM ESTCompany ParticipantsLisa Stoner - Vice President of Investor RelationsJames Rechtin -...

rttnews.com · Nov 6, 2026

Humana Boosts FY26 Outlook - Update

While reporting financial results for the third quarter on Friday, health insurer Humana, Inc. (HUM) raised its earnings and adjusted earnings guidance for the full-year 2026.

gurufocus.com · Oct 16, 2026

A Look at Humana Inc (HUM) After 4.4% Decline -- GF Value $382.97 vs Price $413.16

On October 16, 2026, Humana Inc (HUM) shares fell 4.4% to a current price of $413.16. This decline comes amid a 52-week price range of $163.11 to $456.50, showc

insidermonkey.com · Oct 13, 2026

Humana (HUM) Will Have 95% of Its Members in Four-Star Plans, Up From 20%. What Changed?

Humana Inc. (NYSE:HUM) closed at $420.38 on October 13.

finance.yahoo.com · Sep 3, 2026

Can Better Star Ratings and Margin Expansion Drive Humana (HUM) Higher?

Eagle Capital Management, an investment management company, released its second quarter 2026 investor letter. A copy of the letter can be downloaded here. In the quarter, Eagle Capital Management discussed how enthusiasm around AI capital spending has driven strong S&P 500 earnings growth while also increasing risks from elevated valuations, concentrated demand, and aggressive investment assumptions. […]

Open full news and sentiment

HUM Catalysts FAQ

What are the next catalysts for HUM stock?

HUM's next stock catalysts can include earnings, guidance, analyst ratings, price-target changes, estimate revisions, product updates, regulatory events, contracts, or sector developments. Use this page to connect those events with AIQ and market context.

What upcoming events could move HUM stock?

Upcoming events that could move HUM include earnings reports, management commentary, estimate changes, major news, and market-wide sector catalysts.

How could HUM's next earnings report affect the stock?

HUM's next earnings report could affect the stock by changing revenue expectations, EPS estimates, guidance, analyst ratings, price targets, estimate revisions, and momentum.

What could drive HUM stock higher?

HUM could move higher if earnings, guidance, demand trends, analyst expectations, or AIQ momentum improve relative to what the market already expects.

What events could hurt HUM stock?

HUM could be hurt by weaker guidance, negative estimate revisions, margin pressure, adverse news, regulatory issues, or a sector-wide risk-off move.